F
F2G
1 follower
F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.
Org chart
Francesco Maria Lavino
Collapse
Ralf Schmid
CFO
John H. Rex
Chief Medical Officer
Mike Birch
COO
Tony Kennedy
Chief Scientific & Development Officer
Janelle R. Anderson
Chief Business Officer
Mark Baglin
Chief Commercial Officer
Ana Zaccaro
Vice President Regulatory Affairs
daniela zinzi
VP, Clinical R&D
Mark Bresnik, MD
Executive Director, Clinical R&D
Will West
Non Executive Director
Teams
Offices
Similar companies
REVOLUTION Medicines
5 followers
Owkin
4 followers
Autolus
3 followers
Loam Bio
3 followers
Dyne Therapeutics
3 followers
Premier Research
2 followers
Telix Pharma
2 followers
FUJIFILM Diosynth Biotechnologies
8 followers
Fortis Life Sciences
1 follower
Vividion Therapeutics
1 follower
Cabaletta Bio
1 follower
Explore companies
- Something went wrong loading the org chart, please refresh the page.